Quadramet and vomiting Patient Reports February 12, 2012

Quadramet Side Effects Report #4734214-8
Quadramet side effect was reported by a Health Professional from NETHERLANDS on May 23, 2004. Male patient, 72 years of age, weighting 242.5 lb, was diagnosed with prostate cancer metastatic, pain  and was treated with Quadramet. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hyperhidrosis, nausea , oxygen saturation decreased. Quadramet dosage: unknown. During the same period patient was treated with MORPHINE, TOLTERODINE TARTRATE, BETAHISTINE, ACENOCOUMAROL, VENLAFAXINE, FINASTERIDE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #4734216-1
Quadramet side effect was reported by a Health Professional from NETHERLANDS on June 02, 2004. Male patient, 72 years of age, weighting 242.5 lb, was diagnosed with prostate cancer metastatic, pain  and was treated with Quadramet. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hyperhidrosis, nausea , oxygen saturation decreased. Quadramet dosage: unknown. During the same period patient was treated with ZOMETA, MORPHINE, TOLTERODINE TARTRATE. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #4680196-7
Quadramet side effect was reported by a Physician from on Dec 16, 2004. Male patient, 66 years of age, was diagnosed with metastases to bone and was treated with Quadramet. After drug was administered, patient experienced the following side effects: anorexia, nausea . Quadramet dosage: unknown. During the same period patient was treated with ZOMETA, HORMONES AND RELATED AGENTS. Patient was hospitalized. Patient recovered.

Quadramet Side Effects Report #4660910-7
Quadramet side effect was reported by a Physician from on May 05, 2005. Female patient, 64 years of age, weighting 164.0 lb, was diagnosed with breast cancer  and was treated with Quadramet. After drug was administered, patient experienced the following side effects: disease progression, metastases to liver, nausea , oral intake reduced, weight decreased. Quadramet dosage: unknown. During the same period patient was treated with ULTRACET. Patient died on 04/28/2005.